Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/95037
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Martin, S. | - |
dc.contributor.author | Gan, Z. | - |
dc.contributor.author | Fitter, S. | - |
dc.contributor.author | To, L. | - |
dc.contributor.author | Zannettino, A. | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Leukemia Research, 2015; 39(3):380-387 | - |
dc.identifier.issn | 0145-2126 | - |
dc.identifier.issn | 1873-5835 | - |
dc.identifier.uri | http://hdl.handle.net/2440/95037 | - |
dc.description.abstract | Abstract not available | - |
dc.description.statementofresponsibility | Sally K. Martin, Zhen Ying Gan, Stephen Fitter, Luen B. To, Andrew C.W. Zannettino | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.rights | © 2015 Elsevier Ltd. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.leukres.2014.12.015 | - |
dc.subject | BKM120; Multiple myeloma; Bone; PI3K | - |
dc.title | The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myeloma | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.leukres.2014.12.015 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/1030528 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Martin, S. [0000-0002-5700-3478] | - |
dc.identifier.orcid | Fitter, S. [0000-0003-1663-6807] | - |
dc.identifier.orcid | Zannettino, A. [0000-0002-6646-6167] | - |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.